Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Immunomodulatory therapies delay disease progression in multiple sclerosis.
The cuprizone model: regional heterogeneity of pathology.
Minocycline attenuates iron neurotoxicity in cortical cell cultures.
Treatment of a relapse-remitting model of multiple sclerosis with opioid growth factor.
Reduced sick leave in multiple sclerosis after one year of natalizumab treatment. A prospective ad hoc analysis of the TYNERGY trial.
Deep gray matter demyelination detected by magnetization transfer ratio in the cuprizone model.
Urinary catheterization may not adversely impact quality of life in multiple sclerosis patients.
2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission--II. Biochemical properties.
In vivo anti-LAP monoclonal antibody enhances IL-17/IFN-γ responses and abrogates anti-CD3 induced oral tolerance.
Factors associated with poor sleep quality in patients with multiple sclerosis differ by disease duration.
Neuroscience. To learn is to myelinate.
Expansion of Functional Human Mucosal-Associated Invariant T Cells via Reprogramming to Pluripotency and Redifferentiation.
Roles of the ubiquitin peptidase USP18 in multiple sclerosis and the response to interferon-β treatment.
Myelin oligodendrocyte glycoprotein induces aquaporin-4 autoantibodies in mouse experimental autoimmune encephalomyelitis.
Multiple Sclerosis and Amyotrophic Lateral Sclerosis: Finding and then Losing an Association.
Baseline brain activity changes in patients with clinically isolated syndrome revealed by resting-state functional MRI.
The fraction of varicella zoster virus-specific antibodies among all intrathecally-produced antibodies discriminates between patients with varicella zoster virus reactivation and multiple sclerosis.
Quantitative determination of regional lesion volume and distribution in children and adults with relapsing-remitting multiple sclerosis.
Multiple sclerosis and palliative care - perceptions of severely affected multiple sclerosis patients and their health professionals: a qualitative study.
Interleukin-36γ is expressed by neutrophils and can activate microglia, but has no role in experimental autoimmune encephalomyelitis.
Allelic combinations of immune-response genes as possible composite markers of IFN-β efficacy in multiple sclerosis patients.
Mixed Panniculitis Secondary to Interferon Beta-1a Therapy in a Woman With Multiple Sclerosis.
Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells.
Serum IL-17F does not predict poor response to IM IFNβ-1a in relapsing-remitting MS.
Combinatorial roles for histamine H(1) -H(2) and H(3) -H(4) receptors in autoimmune inflammatory disease of the central nervous system.

Pages